Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Vistin Pharma ASA : Share capital increase registered

Vistin Pharma ASA
Posted on: 09 May 18

Oslo, Norway, 9 May 2018

Vistin Pharma ASA (OSE: VISTIN), reference is made to the Company's announcements on 8 May regarding the approval by the annual general meeting of the Private Placement of 26,785,715 shares at a subscription price of NOK 11.20 per share.

The share capital increase pertaining to the new shares issued in the Private Placement has today been registered with the Norwegian Register of Business Enterprises.

The Company's new registered share capital is NOK 43,840,650 consisting of 43,840,650 shares with a par value of NOK 1.00 per share.

For further information, please contact:

Gunnar Manum
+47 951 79 190

    This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Vistin Pharma ASA via GlobeNewswire

Last updated on: 10/05/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.